HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S-Nitrosoglutathione ameliorates acute renal dysfunction in a rat model of lipopolysaccharide-induced sepsis.

AbstractOBJECTIVE:
Sepsis induces an inflammatory response that results in acute renal failure (ARF). The current study is to evaluate the role of S-Nitrosoglutathione (GSNO) in renoprotection from lipopolysaccharide (LPS)-induced sepsis.
METHODS:
Rats were divided to three groups. First group received LPS (5 mg/kg body weight), second group was treated with LPS + GSNO (50 μg/kg body weight), and third group was administered with vehicle (saline). They were sacrificed on day 1 and 3 post-LPS injection. Serum levels of nitric oxide (NO), creatinine and blood urea nitrogen (BUN) were analysed. Tissue morphology, T lymphocyte infiltrations, and the expression of inflammatory (TNF-α, iNOS) and anti-inflammatory (IL-10) mediators as well as glutathione (GSH) levels were determined.
KEY FINDING:
Lipopolysaccharide significantly decreased body weight and increased cellular T lymphocyte infiltration, caspase-3 and iNOS and decreased PPAR-γ in renal tissue. NO, creatinine and BUN were significantly elevated after LPS challenge, and they significantly decreased after GSNO treatment. TNF-α level was found significantly increased in LPS-treated serum and kidney. GSNO treatment of LPS-challenged rats decreased caspase-3, iNOS, TNF-α, T lymphocyte infiltration and remarkably increased levels of IL-10, PPAR-γ and GSH.
CONCLUSION:
GSNO can be used as a renoprotective agent for the treatment of sepsis-induced acute kidney injury.
AuthorsDevadoss J Samuvel, Anandakumar Shunmugavel, Avtar K Singh, Inderjit Singh, Mushfiquddin Khan
JournalThe Journal of pharmacy and pharmacology (J Pharm Pharmacol) Vol. 68 Issue 10 Pg. 1310-9 (Oct 2016) ISSN: 2042-7158 [Electronic] England
PMID27484743 (Publication Type: Journal Article)
Copyright© 2016 Royal Pharmaceutical Society.
Chemical References
  • Anti-Inflammatory Agents
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Nitric Oxide
  • S-Nitrosoglutathione
  • Creatinine
  • Nitric Oxide Synthase Type II
  • Caspase 3
  • Glutathione
Topics
  • Acute Kidney Injury (blood, chemically induced, drug therapy)
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Blood Urea Nitrogen
  • Caspase 3 (metabolism)
  • Creatinine (blood)
  • Female
  • Glutathione (metabolism)
  • Interleukin-10 (metabolism)
  • Kidney (drug effects, metabolism)
  • Lipopolysaccharides (pharmacology)
  • Nitric Oxide (metabolism)
  • Nitric Oxide Synthase Type II (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • S-Nitrosoglutathione (pharmacology)
  • Sepsis (blood, chemically induced, drug therapy, metabolism)
  • T-Lymphocytes (drug effects)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: